Jacksonville, FLORIDA3 Active Studies

Sarcoma Soft Tissue Clinical Trials in Jacksonville, FLORIDA

Find 3 actively recruiting sarcoma soft tissue clinical trials in Jacksonville, FLORIDA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
864
Enrolling

Recruiting Sarcoma Soft Tissue Studies in Jacksonville

About Sarcoma Soft Tissue Clinical Trials in Jacksonville

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 3 sarcoma soft tissue clinical trials recruiting participants in Jacksonville, FLORIDA. These studies are seeking a combined 864 participants. Research is being sponsored by PharmaMar, Polaris Group, Philogen S.p.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in Jacksonville — FAQ

Are there sarcoma soft tissue clinical trials in Jacksonville?

Yes, there are 3 sarcoma soft tissue clinical trials currently recruiting in Jacksonville, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 3 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated March 2, 2026 from ClinicalTrials.gov